Stock Analiz

Firefly Neuroscience, Inc. AIFF

Computer Software: Prepackaged Software · data as of November 13, 2026

$0.94Market cap $15M
Open the interactive analysis →

Firefly Neuroscience, Inc. (AIFF) is a technology company listed in the US with a market value of about $15M. In the twelve months to September 30, 2026 it had revenue of $2M and net income of -$8M, a net margin of -386.2%.

Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -39% a year, a 5-year average ROIC of -122%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 96% below the current price.

About Firefly Neuroscience

Firefly Neuroscience is listed in the US and classified in computer software: prepackaged software. Revenue went from $6M in 2014 to $1M in 2025, a decline of about 13.7% a year. It was profitable in 2 of the last 10 years in our data. Its share count rose by 603% over three years (dilution for shareholders). It spends 130% of revenue on research and development.

Score: 1.4 / 5

Value0/5
Future growth3/5
Track record0/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S7.2
P/B1.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price−96%

Growth and quality

Revenue growth (1 yr)957.4%
Revenue growth (5 yrs, per year)-39.3%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-2420.8%
ROIC (5-yr avg.)-122.2%
Profitable years (of last 10)2
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$2M$1M$108000$498000$12M$15M$14M$10M$9M$11M$7M
Net income-$8M-$20M-$10M-$3M-$18M-$1M$413379-$717246-$51034$246462-$553681
Free cash flow———-$2M-$7M-$804769$358718-$925514-$769273$835227-$269926
EPS (diluted)$-0.46$-1.97$-1.60$-0.81$-10.03$-0.92$0.31$-0.61$0.00$0.20$-0.51
Net margin-386.2%-1741.0%-9685.2%-522.7%-147.7%-7.5%3.0%-7.1%-0.6%2.3%-8.2%
ROIC—-91.6%—-267.5%—-7.4%19.5%-43.8%-2.6%9.9%-27.3%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Firefly Neuroscience stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 96% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Firefly Neuroscience pay a dividend?

Not currently.

Is Firefly Neuroscience a good stock to buy?

We do not give buy or sell advice. Firefly Neuroscience scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.